Increase of number of shares and votes in Vicore Pharma
Gothenburg, November 29, 2019 – Vicore Pharma Holding AB (publ)’s (“Vicore Pharma”, or the “Company”) registered share capital and number of outstanding shares and votes have increased during the month of November 2019.As previously announced, the Company’s board of directors resolved on November 13, 2019, by virtue of the authorization by the annual general meeting held on May 15, 2019, on a directed share issue of 7,800,000 new shares at a subscription price of SEK 16 per share. Through the share issue, Vicore Pharma received issue proceeds of approximately SEK 125 million before issue